Moderna Plans to Make Up to 3 Billion Vaccine Doses in 2022
- Company is boosting capacity to make mRNA vaccine ingredients
- New investment to double supply at partner Lonza’s Swiss plant
This article is for subscribers only.
Moderna Inc. said it would produce as many as 3 billion doses of its Covid-19 vaccine next year as it makes new investments to bolster output at several factories in the U.S. and Europe.
The biotech company said it would increase supply by 50% at its Norwood, Massachusetts, plant, which makes much of the vaccine substance used in shots for the U.S. market. The investments would also enable partner Lonza Group AG, which is making supply for foreign markets, to double its output at a factory in Switzerland that makes vaccine substance. Vaccine output at third factory in Spain operated by another partner, Laboratorios Farmaceuticos Rovi SA, would also more than double under the plan.